Literature DB >> 33479652

Reversing binding sensitivity to A147T translocator protein.

Sophie V Vo1, Samuel D Banister2,3, Isaac Freelander3, Eryn L Werry3, Tristan A Reekie4, Lars M Ittner5, Michael Kassiou3.   

Abstract

The translocator protein (TSPO) is a target for the development of neuroinflammation imaging agents. Clinical translation of TSPO PET ligands, such as [11C]DPA-713, has been hampered by the presence of a common polymorphism (A147T TSPO), at which all second-generation TSPO ligands lose affinity. Little is known about what drives binding at A147T compared to WT TSPO. This study aimed to identify moieties in DPA-713, and related derivatives, that influence binding at A147T compared to WT TSPO. We found changes to the nitrogen position and number in the heterocyclic core influences affinity to WT and A147T to a similar degree. Hydrogen bonding groups in molecules with an indole core improve binding at A147T compared to WT, a strategy that generated compounds that possess up to ten-times greater affinity for A147T. These results should inform the future design of compounds that bind both A147T and WT TSPO for use in neuroinflammation imaging. This journal is © The Royal Society of Chemistry 2020.

Entities:  

Year:  2020        PMID: 33479652      PMCID: PMC7489257          DOI: 10.1039/c9md00580c

Source DB:  PubMed          Journal:  RSC Med Chem        ISSN: 2632-8682


  34 in total

1.  Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study.

Authors:  Matthias Brendel; Federico Probst; Anna Jaworska; Felix Overhoff; Viktoria Korzhova; Nathalie L Albert; Roswitha Beck; Simon Lindner; Franz-Josef Gildehaus; Karlheinz Baumann; Peter Bartenstein; Gernot Kleinberger; Christian Haass; Jochen Herms; Axel Rominger
Journal:  J Nucl Med       Date:  2016-02-18       Impact factor: 10.057

Review 2.  TSPO in diverse CNS pathologies and psychiatric disease: A critical review and a way forward.

Authors:  Tomás R Guilarte
Journal:  Pharmacol Ther       Date:  2018-09-04       Impact factor: 12.310

3.  Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [¹¹C]DAA1106.

Authors:  Fumihiko Yasuno; Jun Kosaka; Miho Ota; Makoto Higuchi; Hiroshi Ito; Yota Fujimura; Shoko Nozaki; Sho Takahashi; Katsuyoshi Mizukami; Takashi Asada; Tetsuya Suhara
Journal:  Psychiatry Res       Date:  2012-08-11       Impact factor: 3.222

4.  Acute neuroinflammation in a clinically relevant focal cortical ischemic stroke model in rat: longitudinal positron emission tomography and immunofluorescent tracking.

Authors:  Miklós Tóth; Philip Little; Fabian Arnberg; Jenny Häggkvist; Jan Mulder; Christer Halldin; Balázs Gulyás; Staffan Holmin
Journal:  Brain Struct Funct       Date:  2015-01-20       Impact factor: 3.270

5.  Brain inflammation in a chronic epilepsy model: Evolving pattern of the translocator protein during epileptogenesis.

Authors:  Halima Amhaoul; Julie Hamaide; Daniele Bertoglio; Stephanie Nadine Reichel; Jeroen Verhaeghe; Elly Geerts; Debby Van Dam; Peter Paul De Deyn; Samir Kumar-Singh; Andrew Katsifis; Annemie Van Der Linden; Steven Staelens; Stefanie Dedeurwaerdere
Journal:  Neurobiol Dis       Date:  2015-09-24       Impact factor: 5.996

6.  Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain.

Authors:  M Cosenza-Nashat; M-L Zhao; H-S Suh; J Morgan; R Natividad; S Morgello; S C Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2008-12-11       Impact factor: 8.090

7.  In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.

Authors:  William C Kreisl; Chul Hyoung Lyoo; Meghan McGwier; Joseph Snow; Kimberly J Jenko; Nobuyo Kimura; Winston Corona; Cheryl L Morse; Sami S Zoghbi; Victor W Pike; Francis J McMahon; R Scott Turner; Robert B Innis
Journal:  Brain       Date:  2013-06-17       Impact factor: 13.501

8.  Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia.

Authors:  Abraham Martín; Raphaël Boisgard; Benoit Thézé; Nadja Van Camp; Bertrand Kuhnast; Annelaure Damont; Michael Kassiou; Frédéric Dollé; Bertrand Tavitian
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-30       Impact factor: 6.200

9.  Mixed-affinity binding in humans with 18-kDa translocator protein ligands.

Authors:  David R J Owen; Roger N Gunn; Eugenii A Rabiner; Idriss Bennacef; Masahiro Fujita; William C Kreisl; Robert B Innis; Victor W Pike; Richard Reynolds; Paul M Matthews; Christine A Parker
Journal:  J Nucl Med       Date:  2010-12-13       Impact factor: 10.057

10.  Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: assessed with [(11)C]-PBR28.

Authors:  Nicole R Zürcher; Marco L Loggia; Robert Lawson; Daniel B Chonde; David Izquierdo-Garcia; Julia E Yasek; Oluwaseun Akeju; Ciprian Catana; Bruce R Rosen; Merit E Cudkowicz; Jacob M Hooker; Nazem Atassi
Journal:  Neuroimage Clin       Date:  2015-01-19       Impact factor: 4.881

View more
  1 in total

Review 1.  Imaging neuroinflammation with TSPO: A new perspective on the cellular sources and subcellular localization.

Authors:  Tomás R Guilarte; Alexander N Rodichkin; Jennifer L McGlothan; Arlet Maria Acanda De La Rocha; Diana J Azzam
Journal:  Pharmacol Ther       Date:  2021-11-27       Impact factor: 13.400

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.